Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

JDOC vs RSPH overlap: 23% of top holdings shared

Bottom line

How much do JDOC and RSPH overlap?

23% of their top holdings overlap by weight. 7 securities appear in both funds' top 25, making up 23.6% of JDOC's assets and 12.9% of RSPH's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

JDOCRSPH
Weight overlap (top 25)23%
Shared holdings7
Weight in shared holdings23.6%12.9%
Total positions6163
Expense ratio0.65%0.4%
Holdings as ofJul 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Holdings JDOC and RSPH have in common

Holding% of JDOC% of RSPHOverlap
AbbVie, Inc.7.85%1.73%1.73%
Thermo Fisher Scientific, Inc.3.73%1.84%1.84%
Bristol-Myers Squibb Co.3.57%1.82%1.82%
Abbott Laboratories3.11%1.83%1.83%
Cencora, Inc.2.07%1.71%1.71%
IQVIA Holdings, Inc.1.71%2.00%1.71%
Regeneron Pharmaceuticals, Inc.1.60%1.96%1.60%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in JDOC

  1. Eli Lilly & Co. — 7.76%
  2. UnitedHealth Group, Inc. — 5.85%
  3. Merck & Co., Inc. — 4.82%
  4. Johnson & Johnson — 4.82%
  5. AstraZeneca plc — 3.76%
  6. CVS Health Corp. — 2.83%
  7. Roche Holding AG — 2.82%
  8. Novo Nordisk A/S — 2.61%
  9. GSK plc — 2.47%
  10. Stryker Corp. — 2.23%
  11. Danaher Corp. — 2.16%
  12. Argenx SE — 2.06%
  13. Intuitive Surgical, Inc. — 1.93%
  14. Edwards Lifesciences Corp. — 1.73%
  15. Teva Pharmaceutical Industries Ltd. — 1.60%

Only in RSPH

  1. Bio-Techne Corp. — 2.13%
  2. Baxter International Inc. — 1.99%
  3. Mettler-Toledo International Inc. — 1.94%
  4. Charles River Laboratories International, Inc. — 1.93%
  5. Veeva Systems Inc. — 1.93%
  6. DaVita Inc. — 1.87%
  7. Moderna, Inc. — 1.85%
  8. Universal Health Services, Inc. — 1.80%
  9. Labcorp Holdings Inc. — 1.78%
  10. Quest Diagnostics Inc. — 1.77%
  11. Amgen Inc. — 1.77%
  12. Incyte Corp. — 1.76%
  13. Becton, Dickinson and Co. — 1.73%
  14. DexCom, Inc. — 1.73%
  15. Viatris Inc. — 1.72%

Asset mix

Asset typeJDOCRSPH
Stocks99.2%99.9%
Cash & short-term funds—2.3%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Country mix

CountryJDOCRSPH
US75.2%98.9%
GB6.2%—
CH4.4%—
DK4.0%—
IE0.4%3.4%
JP2.5%—
NL2.4%—
DE1.9%—

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do JDOC and RSPH overlap?
About 23% by weight. 7 securities appear in both funds' top 25 holdings; they make up 23.6% of JDOC's assets and 12.9% of RSPH's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do JDOC and RSPH have in common?
The largest shared holdings are Thermo Fisher Scientific, Inc., Abbott Laboratories, Bristol-Myers Squibb Co., AbbVie, Inc., Cencora, Inc..
Should I own both JDOC and RSPH?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, JDOC or RSPH?
RSPH is broader, with 63 positions versus 61 for JDOC. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.